Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

What Really Happened In Wuhan?

Daily Remedy by Daily Remedy
May 30, 2022
in Politics & Law
0
What Really Happened in Wuhan?

A few days ago, a letter was published in a major academic journal. It should have been ground-breaking, but it hardly registered a blip on the media radar.

It was a letter from Dr. Jeffrey Sachs, written in the Proceedings of the National Academy of Sciences, calling for an independent investigation into the origins of COVID-19. He claims the evidence for a lab leak hypothesis is overwhelming and that many academic institutions already possess the evidence to verify as much.

Most notably, he calls out the implausibility of the COVID-19 mutation. What is known as a frame-shift mutation, in which a sequence of eight consecutive amino acids on a critical part of the virus’s spike protein is identical to an amino acid sequence found in cells that line human airways. This is rare enough. But it goes from rare to suspicious when you consider that this mutation is the same one proposed in a 2018 federal grant proposal to DARPA (Defense Advanced Research Projects Agency) by EcoHealth Alliance, the company performing gain-of-function research in Wuhan, China.

People can be forgiven for being incredulous of the notion that the virus mutated naturally. We have a rare mutation sparking a frame-shift mutation in amino acids that led to a pandemic; and it also happens to be the same mutation proposed in a federal research grant just a year prior? Certainly, this suggests there is at least the possibility that the mutation was man-made. But we have already witnessed the whiplash from the powers that be in giving credence to any thought of a lab leak hypothesis.

Even the Chinese government has prevented any major investigation in or around the town of Wuhan where COVID-19 originated. Why the silence? It does nothing to silence the debate. It only makes the suspicions grow stronger.

It highlights a concerning trend in public policy. Instead of debates, we attack those who do not agree with us. Instead of challenging the issue or prevailing scientific notion, we challenge those who present with countervailing points. Any disagreement is an instant battle of wills.

It is hard to pinpoint when this began. Most assume it started during the pandemic. Actually, it began far earlier. Some say political polarizations began in the 90’s and has only escalated since then. But how health policy become polarized is less about political polarization itself, and more about how politics crept into policy – and not just any policy, but health policy.

Some say it began in the 80’s, when politicians began tinkering with health insurance policies. But for the most part, most think it began with the Affordable Care Act, the policy that became a modern-day referendum on political allegiances. As soon as the law passed, it was challenged, and litigated, and then challenged some more.

It quickly became the rallying cry to either support or attack President Obama. The partisan structure of debate on the issue mirrored more of an electoral competition between Republicans and Democrats than a traditional situation of interest group politics. Soon enough, politicians began campaigning on the issue.

Once it became a voting issue, it divided along those lines. Now there is no room for debate. We simply posture a pre-existing position and select data that supports what we think – until what we believe is all that there is to believe.

This is why we will never have a meaningful investigation into the origins of COVID-19. Healthcare has become a voting issue, and no one votes for a compromise.

Just ask President Trump, who even years after he lost the 2020 presidential election, refuses to acknowledge defeat – and his voters love him for it.

It seems years after this pandemic takes its toll, we will continue to see the same grandstanding among scientists and politicians. Time will sadly do little to ease the existing tension. And we will continue to fight and litigate data, mutation probabilities, and find even more conspiracies. Each side on the matter will remain unwilling to recant even a modicum of ground since compromise is considered weakness.

And voters never support weakness. Just ask Trump. Actually, just ask Antony Fauci, MD.

 

Political Polarization in the American Public

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • What is the 411 on the New 988 Hotline?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy